Paul Carter

Senior Director of Business Development & Licensing, North America at ERS Genomics

Paul has over 20 years of multidisciplinary technical and international licensing experience. He joined ERS from Washington University in St. Louis where he was Business Development Director in the office of technology management. While there he was responsible for the commercialization of life science, healthcare, and engineering technologies. This included negotiating complex license agreements with companies, overseeing patent prosecution, serving on the board of select startups, and managing an accelerator for proactive startup formation.

Paul was previously Director of Intellectual Property Licensing for IBM with worldwide responsibility for licensing semiconductor, networking, display, healthcare and life science technologies. Paul holds undergraduate and graduate engineering degrees from the Missouri University of Science and Technology.

Location

St. Louis, United States

Links

Previous companies


Org chart

No direct reports

Teams

This person is not in any teams


Offices

This person is not in any offices


ERS Genomics

1 followers

ERS Genomics was formed to commercialize the foundational CRISPR-Cas9 intellectual property held by co-inventor, co-owner, and Nobel Prize-winner Dr. Emmanuelle Charpentier. Licenses are available in multiple fields of use.


Industries

Employees

11-50

Links